<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-714X</journal-id>
<journal-title><![CDATA[Revista de la OFIL ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. OFIL·ILAPHAR]]></abbrev-journal-title>
<issn>1699-714X</issn>
<publisher>
<publisher-name><![CDATA[Organización de Farmacéuticos Ibero-Latinoamericanos]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-714X2021000300321</article-id>
<article-id pub-id-type="doi">10.4321/s1699-714x20210003000012</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Administración de amoxicilina a un paciente con mononucleosis infecciosa. Reporte de un caso de reacción adversa]]></article-title>
<article-title xml:lang="en"><![CDATA[Amoxicillin administration to a patient with infectious mononucleosis. Report of an adverse reaction case]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cavigliasso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gola]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valentín]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Seguro]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romañuk]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Córdoba Facultad de Ciencias Químicas Departamento de Ciencias Farmacéuticas]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Córdoba Facultad de Ciencias Químicas ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Sanatorio Privado Aconcagua Servicio de Farmacia ]]></institution>
<addr-line><![CDATA[Córdoba ]]></addr-line>
<country>Argentina</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<volume>31</volume>
<numero>3</numero>
<fpage>321</fpage>
<lpage>323</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-714X2021000300321&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-714X2021000300321&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-714X2021000300321&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Describir un caso clínico de un paciente tratado con amoxicilina (AMX) mientras cursaba una infección viral, en el que se detectaron errores de medicación (EM) y reacciones adversas a medicamentos (RAM). Descripción del caso clínico: Paciente masculino de 7 años y 23 kg concurrió a la guardia del hospital presentando fatiga, fiebre y ganglios linfáticos inflamados. Se diagnosticó faringitis bacteriana y se indicó AMX 50 mg/kg/día vía oral/8 h. Al día siguiente, el paciente fue nuevamente al hospital presentando rash cutáneo en todo el cuerpo. Se advirtió evento adverso (EA) por diagnóstico erróneo y se diagnosticó mononucleosis infecciosa (MI). Se suspendió la AMX y hubo remisión del rash. Un farmacéutico hospitalario realizó la imputación utilizando el algoritmo de Naranjo (puntaje 5-8) y notificó al Sistema Unificado de Farmacovigilancia de Córdoba.  Discusión:  Es fundamental el diagnóstico adecuado de la MI para evitar el uso inapropiado de antibióticos ante una infección viral. En el caso descripto ocurrió un EM en la etapa de prescripción, debido al diagnóstico incorrecto, y una RAM por el uso de AMX. El puntaje obtenido permitió catalogar a esta RAM como probable, no pudiendo ser considerada definida/probada por no haber reexposición; aunque el EA apareció luego de la administración de un fármaco sospechoso y no existieron causas alternativas para explicar esta reacción. Además, el EA desapareció tras suspender la AMX. Esto enfatiza el rol protagónico del farmacéutico para promover la seguridad de pacientes y la importancia de las notificaciones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Goal:  To describe a clinical case of a patient treated with amoxicillin (AMX) while he had a viral infection. In this case, medication error (ME) as well as adverse drug reaction (ADR) were detected. Description of the clinical case: A 7-year-old, 23-kg male patient attended to the hospital with the following symptoms: fatigue, fever and swollen lymph nodes. Pharyngitis caused by bacteria was diagnosed and orally administration of AMX 50 mg/kg/day each 8 h was indicated. One day later, the patient returned to the hospital with skin rash throughout the body. An adverse event (AE) was noticed due to an error in the diagnosis, which was corrected and infectious mononucleosis (MI) was detected. AMX was suspended and remission of the rash was observed. A hospital pharmacist performed the imputation using the Naranjo algorithm (score 5-8) and notified to the Sistema Unificado de Farmacovigilancia of Cordoba.  Discussion:  Proper diagnosis of IM is essential to avoid inappropriate use of antibiotics when the patients present viral infections. In this clinical case, a ME occurred at the prescription, due to the incorrect diagnosis, and an ADR because of the use of AMX. The score obtained allowed us to classify this ADR as probable, and it could not be considered definite/proven because there was no re-exposure. However, the AE occurred after the administration of a suspected drug and there were no alternative causes to explain this reaction. In addition, the AE disappeared after suspending the AMX. This emphasizes the leading role of the pharmacist in promoting patient safety and the relevance of notifications.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Amoxicilina]]></kwd>
<kwd lng="es"><![CDATA[mononucleosis infecciosa]]></kwd>
<kwd lng="es"><![CDATA[reacción adversa]]></kwd>
<kwd lng="es"><![CDATA[error de medicación]]></kwd>
<kwd lng="en"><![CDATA[Amoxicillin]]></kwd>
<kwd lng="en"><![CDATA[infectious mononucleosis]]></kwd>
<kwd lng="en"><![CDATA[adverse reaction]]></kwd>
<kwd lng="en"><![CDATA[medication error]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[VJO]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<source><![CDATA[La seguridad del paciente: principios y recorrido histórico. La seguridad del paciente en la práctica clínica]]></source>
<year>2019</year>
<page-range>6-26</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[BRYSEMfarma, S.L]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[VJO]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<source><![CDATA[Seguridad en el uso de los medicamentos. La seguridad del paciente en la práctica clínica]]></source>
<year>2019</year>
<page-range>105-39</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[BRYSEMfarma, S.L]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akhavan]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vijhani]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Amoxicillin. StatPearls]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Treasure Island (FL) ]]></publisher-loc>
<publisher-name><![CDATA[StatPearls Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van der Linden]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[van der Lei]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vlug]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Stricker]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin reactions to antibacterial agents in general practice]]></article-title>
<source><![CDATA[Journal of Clinical Epidemiology]]></source>
<year>1998</year>
<volume>51</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>703-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ónodi-Nagy]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kinyó]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Meszes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Garaczi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kemény]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bata-Csörgo]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization.]]></article-title>
<source><![CDATA[Allergy, Asthma, Clinical Immunology]]></source>
<year>2015</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-4</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ebell]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epstein-Barr virus infectious mononucleosis.]]></article-title>
<source><![CDATA[American family physician]]></source>
<year>2004</year>
<volume>70</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1279-87</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ebell]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Call]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shinholser]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gardner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Does this patient have infectious mononucleosis?: The rational clinical examination systematic review]]></article-title>
<source><![CDATA[Clinical Review &amp; Education]]></source>
<year>2016</year>
<volume>315</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1502-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Renn]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Straff]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Dorfmüller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Masaoudi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Merk]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sachs]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity]]></article-title>
<source><![CDATA[British Journal of Dermatology]]></source>
<year>2002</year>
<volume>147</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1166-70</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>Ministerio de Salud (MSN)</collab>
<source><![CDATA[Administración Nacional de medicamentos aytmA. Guía de Buenas Prácticas de Farmacovigilancia]]></source>
<year>2009</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
